Skip to main content
NCBI home page
Gut logoLink to Gut
. 2001 May;48(5):667–670. doi: 10.1136/gut.48.5.667

Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer

S Dexter 1, H Sue-Ling 1, M McMahon 1, P Quirke 1, N Mapstone 1, I Martin 1
PMCID: PMC1728263  PMID: 11302966

Abstract

BACKGROUND—For rectal carcinoma, the presence of tumour within 1 mm of the circumferential margin is an important independent prognostic factor for both local recurrence and survival. Similar prospective data have not been reported for oesophageal carcinoma and we wished to ascertain the prognostic importance of this variable following potentially curative resection for oesophageal carcinoma.
AIM—To prospectively assess the impact of circumferential margin involvement (tumour within 1 mm) following potentially curative resection for oesophageal carcinoma.
PATIENTS AND METHODS—In a prospective study, resection specimens of 135 patients treated with potentially curative oesophageal resection alone were studied for the presence of tumour within 1 mm of the circumferential margin (margin positive), using inked margins and cross sectional slicing of the specimen. All tumours were also staged using the 1987 UICC TNM classification. Patients were followed for a mean of 19 months, and overall and cancer specific survival analysed.
RESULTS—The finding of tumour cells within 1 mm of the circumferential margin (CRM+) was a significant and independent predictor of survival following potentially curative oesophageal resection. Overall, 64 (47%) patients were CRM+. Median survival in this group was 21 months compared with 39 months in the CRM− group (p=0.015). The impact of CRM status on survival was only seen in patients with a low nodal metastatic burden (<25% nodes positive). The odds ratio for the risk of dying from oesophageal cancer was 2.08 when the CRM was involved (p=0.013).
CONCLUSIONS—The presence of tumour within 1 mm of the circumferential margin following potentially curative resection for oesophageal carcinoma is an important independent prognostic variable and should be reported routinely.


Keywords: oesophageal cancer; survival; circumferential resection margin

Full Text

The Full Text of this article is available as a PDF (114.2 KB).

Figure 1  .

Figure 1  

Open in a new tab

Oesophageal cancer resection specimen following inking of the margins and serial cross sectional sequential slicing

Figure 2  .

Figure 2  

Open in a new tab

Overall cancer specific survival for patients with (broken line) and without (solid line) tumour within 1 mm of the circumferential resection margin.

Figure 3  .

Figure 3  

Open in a new tab

Survival for patients with less than 25% of involved nodes, with (broken line) and without (solid line) tumour within 1 mm of the circumferential resection margin

Figure 4  .

Figure 4  

Open in a new tab

Survival for patients with more than 25% of involved nodes, with (broken line) and without (solid line) tumour within 1 mm of the circumferential resection margin

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam I. J., Mohamdee M. O., Martin I. G., Scott N., Finan P. J., Johnston D., Dixon M. F., Quirke P. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994 Sep 10;344(8924):707–711. doi: 10.1016/s0140-6736(94)92206-3. [DOI] [PubMed] [Google Scholar]
  2. Akiyama H., Tsurumaru M., Udagawa H., Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994 Sep;220(3):364–373. doi: 10.1097/00000658-199409000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Altorki N. K., Girardi L., Skinner D. B. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997 Dec;114(6):948–956. doi: 10.1016/S0022-5223(97)70009-6. [DOI] [PubMed] [Google Scholar]
  4. Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F., Jr Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991 Mar 13;265(10):1287–1289. [PubMed] [Google Scholar]
  5. Bosset J. F., Gignoux M., Triboulet J. P., Tiret E., Mantion G., Elias D., Lozach P., Ollier J. C., Pavy J. J., Mercier M. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997 Jul 17;337(3):161–167. doi: 10.1056/NEJM199707173370304. [DOI] [PubMed] [Google Scholar]
  6. Kawahara K., Maekawa T., Okabayashi K., Shiraishi T., Yoshinaga Y., Yoneda S., Hideshima T., Shirakusa T. The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol. 1998 Mar;67(3):160–163. doi: 10.1002/(sici)1096-9098(199803)67:3<160::aid-jso3>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  7. Korst R. J., Rusch V. W., Venkatraman E., Bains M. S., Burt M. E., Downey R. J., Ginsberg R. J. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg. 1998 Mar;115(3):660–670. doi: 10.1016/S0022-5223(98)70332-0. [DOI] [PubMed] [Google Scholar]
  8. Law S. Y., Fok M., Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg. 1996 Jan;83(1):107–111. doi: 10.1002/bjs.1800830134. [DOI] [PubMed] [Google Scholar]
  9. Lieberman M. D., Shriver C. D., Bleckner S., Burt M. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg. 1995 Jan;109(1):130–139. doi: 10.1016/S0022-5223(95)70428-0. [DOI] [PubMed] [Google Scholar]
  10. Nishimaki T., Suzuki T., Tanaka Y., Nakagawa S., Aizawa K., Hatakeyama K. Evaluating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus. Surg Today. 1997;27(1):3–8. doi: 10.1007/BF01366932. [DOI] [PubMed] [Google Scholar]
  11. Sagar P. M., Johnston D., McMahon M. J., Dixon M. F., Quirke P. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg. 1993 Nov;80(11):1386–1388. doi: 10.1002/bjs.1800801109. [DOI] [PubMed] [Google Scholar]
  12. Sun K., Zhang R., Zhang D., Huang G., Wang L. Prognostic significance of lymph node metastasis in surgical resection of esophageal cancer. Chin Med J (Engl) 1996 Jan;109(1):89–92. [PubMed] [Google Scholar]
  13. Veronesi U., Salvadori B., Luini A., Greco M., Saccozzi R., del Vecchio M., Mariani L., Zurrida S., Rilke F. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer. 1995 Sep;31A(10):1574–1579. doi: 10.1016/0959-8049(95)00271-j. [DOI] [PubMed] [Google Scholar]
  14. Walsh T. N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T. P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996 Aug 15;335(7):462–467. doi: 10.1056/NEJM199608153350702. [DOI] [PubMed] [Google Scholar]
  15. al-Sarraf M., Martz K., Herskovic A., Leichman L., Brindle J. S., Vaitkevicius V. K., Cooper J., Byhardt R., Davis L., Emami B. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997 Jan;15(1):277–284. doi: 10.1200/JCO.1997.15.1.277. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES